KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Current Taxes (2016 - 2026)

Biogen has reported Current Taxes over the past 18 years, most recently at $93.6 million for Q1 2026.

  • For Q1 2026, Current Taxes fell 85.05% year-over-year to $93.6 million; the TTM value through Mar 2026 reached $93.6 million, down 85.05%, while the annual FY2025 figure was $114.8 million, 79.06% down from the prior year.
  • Current Taxes for Q1 2026 was $93.6 million at Biogen, down from $114.8 million in the prior quarter.
  • Over five years, Current Taxes peaked at $626.1 million in Q1 2025 and troughed at $93.6 million in Q1 2026.
  • A 5-year average of $277.0 million and a median of $257.4 million in 2023 define the central range for Current Taxes.
  • Biggest five-year swings in Current Taxes: soared 170.8% in 2025 and later tumbled 85.05% in 2026.
  • Year by year, Current Taxes stood at $259.9 million in 2022, then fell by 0.96% to $257.4 million in 2023, then soared by 113.01% to $548.3 million in 2024, then tumbled by 79.06% to $114.8 million in 2025, then dropped by 18.47% to $93.6 million in 2026.
  • Business Quant data shows Current Taxes for BIIB at $93.6 million in Q1 2026, $114.8 million in Q4 2025, and $103.3 million in Q3 2025.